Brief: Nicox announces U.S. Patents For Latanoprostene Bunod Eligible For Patent Term Extension
22/04/2021 07:13
April 22 (Reuters) - Nicox SA NCOX.PA :
* U.S. PATENTS FOR NICOX’S LATANOPROSTENE BUNOD,
COMMERCIALIZED AS
VYZULTA®, ELIGIBLE FOR PATENT TERM EXTENSION
Source text for Eikon: ID:nGNE4nSMRL
Further company coverage: NCOX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))